Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Nausea 1

Interventions

pembrolizumab 2sintilimab 1nabiximols 1camrelizumab 1anlotinib 1Platinum Compounds 1Palonosetron 1Olanzapine 1Drug Therapy 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Squamous Cell Carcinoma of Head and Neck × Olanzapine × Clear all
NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown
43 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡